Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.360
+0.140 (11.48%)
At close: May 13, 2025, 4:00 PM
1.380
+0.020 (1.47%)
Pre-market: May 14, 2025, 8:52 AM EDT
Intelligent Bio Solutions Employees
Intelligent Bio Solutions had 50 employees as of June 30, 2024. The number of employees decreased by 1 or -1.96% compared to the previous year.
Employees
50
Change (1Y)
-1
Growth (1Y)
-1.96%
Revenue / Employee
$58,729
Profits / Employee
-$205,258
Market Cap
9.23M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
INBS News
- 1 day ago - Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements - GlobeNewsWire
- 8 days ago - Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion - GlobeNewsWire
- 22 days ago - Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra - GlobeNewsWire
- 7 weeks ago - Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - GlobeNewsWire
- 7 weeks ago - Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch - GlobeNewsWire